Anemia and survival in chronic obstructive pulmonary disease: A dichotomous rather than a continuous predictor

Respiration

Volumn 85, Issue 2, 2013, Pages 126-131

  Boutou, Afroditi K ^a,b   Karrar, Sarah ^a   Hopkinson, Nicholas S ^a   Polkey, Michael I ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Anemia; Chronic obstructive pulmonary disease; Forced expiratory volume in 1 second

Indexed keywords

AGED; AMBIENT AIR; ANEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD OXYGEN TENSION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MORTALITY; OUTPATIENT; POLYCYTHEMIA; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SPIROMETRY; SURVIVAL; SURVIVAL RATE; SURVIVOR; CARBON DIOXIDE TENSION; FORCED VITAL CAPACITY; HEMOGLOBIN BLOOD LEVEL; LUNG FUNCTION; OXYGEN TENSION; OXYGEN THERAPY;

AGE FACTORS; AGED; ANEMIA; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

HEMOGLOBIN;

EID: 84874106800     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000338792     Document Type: Article

References (36)

1. Viegi G, Pistelli F, Sherrill DL, Maio S, Bal-dacci S, Carrozzi L: Definition, epidemiology and natural history of COPD. Eur Respir J 2007; 30: 993-1013.
2. Stockley RA, Mannino D, Barnes PJ: Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6:524-526.
3. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B: Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29: 923-929.
4. Almagro P, Calbo E, Ochoa de EA, Barreiro B, Quintana S, Heredia JL, Garau J: Mortality after hospitalization for COPD. Chest 2002; 121:1441-1448.
5. Marin JM, Cote CG, Diaz O, Lisboa C, Casanova C, Lopez M V, Carrizo SJ, Pinto-Plata V, Dordelly LJ, Nekach H, Celli BR: Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med 2011; 105: 916-921.
6. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, Magnussen H: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140: 331-342.
7. Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF: Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006; 4:17.
8. Krishnan G, Grant BJ, Muti PC, Mishra A, Ochs-Balcom HM, Freudenheim JL, Trevi-san M, Schunemann HJ: Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006; 6: 23.
9. Similowski T, Agusti A, MacNee W, Schon-hofer B: The potential impact of anaemia of chronic disease in COPD. Eur Respir J 2006; 27: 390-396.
10. Boutou AK, Stanopoulos I, Pitsiou GG, Kon-takiotis T, Kyriazis G, Sichletidis L, Argyro-poulou P: Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration 2011; 82: 237-245.
11. Morbidity and mortality of dialysis. NIH Consens Statement 1993; 11:1-33.
12. Karhausen T, Anker SD, Doehner W: Anemia in chronic heart failure-clinical and prognostic significance. Curr Med Chem Cardiovasc Hematol Agents 2005; 3:297-303.
13. Blohmer JU, Dunst J, Harrison L, Johnston P, Khayat D, Ludwig H, O'Brien M, Van BS, Vaupel P: Cancer-related anemia: biological findings, clinical implications and impact on quality of life. Oncology 2005; 68(suppl 1):12-21.
14. Chambellan A, Chailleux E, Similowski T: Prognostic value of the hematocrit in patients w it h severe COPD receiving long-ter m oxygen therapy. Chest 2005; 128:1201-1208.
15. Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
16. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA), 2010.
17. Guralnik JM, Ershler WB, Schrier SL, Pi-cozzi VJ: Anemia in the elderly: a public health crisis in hematology. Hematology Am Soc Hematol Educ Program 2005; 528-532.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
19. Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
20. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP: Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-1861.
21. van Helvoort HA, Heijdra YF, Dekhuijzen PN: Systemic immunological response to exercise in patients with chronic obstructive pulmonary disease: what does it mean? Respiration 2006; 73: 255-264.
22. Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
23. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-1276.
24. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagana X, Gayete A, Pare C, Freixa X, Ferrer J, Ferrer A, Roca J, Galdiz JB, Sauleda J, Monso E, Gea J, Barbera JA, Agusti A, Anto JM: Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66:430-437.
25. Kung C, Wang H, Tseng Z: Cigarette smoking exacerbates health problems in young men. Clin Invest Med 2008; 31:E138-E149.
26. Milman N, Pedersen A: Blood haemoglobin concentrations are higher in smokers and heavy alcohol consumers than in non-smokers and abstainers: should we adjust the reference range? Ann Hematol 2009; 88:687-694.
27. Godtfredsen N, Lam T, Hansel T, Leon M, Gray N, Dresler C, Burns D, Prescott E, Vestbo J: COPD-related morbidity and mortality after smoking cessation: level of the evidence. Eur Respir J 2008; 844-853.
28. Zielinski J: Effects of long-term oxygen therapy in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999; 5: 81-87.
29. Renzetti AD Jr, McClement JH, Litt BD: The Veterans Administration cooperative study of pulmonary function. 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Am J Med 1966; 41:115-129.
30. Palazzuoli A, Silverberg D, Iovine F, Capo-bianco S, Giannotti G, Calabro A, Campa-gna SM, Nuti R: Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 2006; 152:1096-1015.
31. Streeter R, Mancini D: Treatment of anemia in the patient with heart failure. Curr Treat Options Cardiovasc Med 2005; 7:327-332.
32. Locatelli F, Pozzoni F, Vechio L: Recombi-nant human epoetin beta in the treatment of renal anemia. Ther Clin Risk Manag 2007; 3: 433-439.
33. John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD: Anemia and inflammation in COPD. Chest 2005; 127:825-829.
34. Boutou A, Pitsiou G, Stanopoulos I, Kyriazis G, Argyropoulou P: Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM 2012, E-pub ahead of print.
35. Incalzi RA, Corsonello A, Pedone C, Batta-glia S, Paglino G, Bellia V: Chronic renal failure: a neglected comorbidity of COPD. Chest 2010; 137: 831-837.
36. Zachee P, Vermylen J, Boogaerts MA: Hema-tologic aspects of end-stage renal failure. Ann Hematol 1994; 69:33-40.